Perrigo files ANDA for topical hair re-growth treatment

ALLEGAN, Mich. Perrigo on Tuesday announced that it has filed an abbreviated new drug application for over-the-counter minoxidil topical aerosol foam, 5%, a generic form of Men’s Rogaine Foam, a topical hair re-growth treatment indicated for the re-growth of hair on top of the scalp. Johnson & Johnson’s Men’s Rogaine Foam has estimated sales at retail of approximately $52 million annually, Perrigo reported.

“This is another example of how our ongoing focus on innovation and consistently bringing new products to market saves consumers money,” stated Perrigo chairman and CEO Joseph Papa. “Over the past 15 years Perrigo products have saved consumers over an estimated $10 billion compared to the national brand.”